Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Download bibliography of all 8,032 studies, highest score first: BibTeX (.bib) · RIS (.ris)

Highest usefulness score first. Studies without a score come last.

  1. Frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. The Lancet. Neurology 2005-11-01 Lewy body dementia

    Frontotemporal dementia (FTD) is a focal clinical syndrome characterised by profound changes in personality and social conduct and associated with circumscribed degeneration of the prefrontal and anterior temporal cortex.

    Why it matters

    This review describes frontotemporal dementia as a focal clinical syndrome with circumscribed degeneration of the prefrontal and anterior temporal cortex and notes that many cases show no apparent tau abnormality. It is a review, not a treatment, cure or prevention for Alzheimer's disease.

  2. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Stroke 2005-09-22 Brain scans and imaging

    The new MRI rating scale for WMH in cholinergic pathways is reliable and shows stronger correlations with cognitive performance than a general WMH rating scale in AD with WMH.

    Why it matters

    A new rating scale for white matter hyperintensities within cholinergic pathways was reliable and was associated with impaired performance on the Mattis Dementia Rating Scale, accounting for 12% of the variance. A similar model was not significant for general white matter hyperintensity scores.

  3. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2005-08-01 Brain scans and imaging

    A profile of equal impairment on tests of executive control and memory along with radiologic evidence involving about one-fourth of the cerebral white matter as measured by the Leukoaraiosis Scale may be sufficient for a diagnosis of subcortical vascular dementia.

    Why it matters

    Neuropsychological measures accounted for 60.7% of the variance in white matter abnormality severity, with executive and visuoconstructive test performance contributing most. Only patients with mild white matter abnormalities showed greater impairment on memory and language tests than on executive control and visuoconstructive tests.

  4. Conceptions of dementia in a multiethnic sample of family caregivers

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of the American Geriatrics Society 2005-08-01 Disparities

    Understanding variability in conceptions of dementia in multiethnic populations is important to improve care and guide research.

    Why it matters

    In a multiethnic sample of family dementia caregivers, 54% held explanatory models combining folk and biomedical elements, and minority caregivers were more likely to do so. This describes how families understand dementia and may help guide care and research, but it does not treat, cure, or prevent the disease.

  5. Early and late life cognitive activity and cognitive systems in old age

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of the International Neuropsychological Society : JINS 2005-07-01 Brain tissue and pathology

    Little is known about the relative benefits of cognitively stimulating activities at different points in the lifespan.

    Why it matters

    In 576 older persons without dementia, past cognitive activity and resources were positively correlated with current cognitive activity and function, though the association with cognitive function was reduced after controlling for other factors. This is an observational study and does not show that cognitive activity prevents Alzheimer's disease.

  6. Cerebral small-vessel disease and decline in information processing speed, executive function and memory

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Brain : a journal of neurology 2005-06-09 Vascular contributions

    Cerebral small-vessel disease is common in older people and may contribute to the development of dementia.

  7. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. European journal of clinical nutrition 2005-04-01 Vascular contributions

    Although internal factors explain most about the poor nutritional status of aged residents in nursing homes, the factors related to nutritional care need further investigation to clarify their role in maintaining the nutritional status of aged residents.

  8. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurobiology of Aging 2005 Brain scans and imaging

    Why it matters

    Reports measures of brain structure and infarction in the Framingham Heart Study, aimed at establishing what is normal.

  9. Prognostic significance of delirium in frail older people

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Dementia and geriatric cognitive disorders 2004-12-23 Clinical safety

    Our aim was to investigate the long-term prognosis of delirium in the frailest elderly, and to clarify whether delirium is just a marker of the underlying severe disease.

  10. Sleep and quantitative EEG in neurodegenerative disorders

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of psychosomatic research 2004-05-01 Risk factors

    This paper reviews current knowledge on sleep problems, sleep architecture changes and quantitative EEG alteration brought on by various neurodegenerative diseases, such as Alzheimer's disease (AD), progressive supranuclear palsy (PSP), REM sleep behavior disorder (RBD), Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy MSA, Huntington's disease and Creutzfeldt-Jakob disease, in comparison to normal aging.

    Why it matters

    This review describes how sleep problems, changes in sleep architecture, and quantitative EEG changes occur in Alzheimer's disease and other neurodegenerative diseases compared with normal aging. It suggests that studying sleep and EEG may help understand these diseases and assist with diagnosis, but it does not report any treatment or cure.

  11. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Diabetes 2004-03-01 Vascular contributions

    Diabetic patients are at increased risk for stroke, but little is known about the presence of other brain lesions.

  12. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. AIDS (London, England) 2004-01-01 Prevention and risk

    Individuals over 50 years of age comprise 11% of AIDS cases reported to the Centers for Disease Control and Prevention.

    Why it matters

    Existing data suggest, but have not conclusively shown, that older HIV-positive individuals may have higher rates of HIV-associated dementia than younger ones. Factors that may explain this susceptibility include interactions with other dementias, vascular co-pathology, age-related immune changes, and reduced compensatory ability of the aging brain.

  13. Mild cognitive impairment: directions for future research

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2003-08-01 Mild cognitive impairment

    Mild cognitive impairment (MCI), an intermediate state between normal aging and dementia, is characterized by acquired cognitive deficits, without significant decline in functional activities of daily living.

    Why it matters

    This article discusses the need for uniform methods to diagnose mild cognitive impairment and to measure changes in cognition and function, noting that neuroimaging and genetic testing can help identify people at increased risk of dementia. It is about research methodology and does not report any treatment, cure, or prevention.

  14. Mild cognitive impairment in older people

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Lancet (London, England) 2002-12-01 Prevention and risk

    As public awareness of Alzheimer's disease increases, more people are asking for help and advice about memory problems.

    Why it matters

    This article describes amnestic mild cognitive impairment as a state in which memory loss is not severe enough to merit a dementia diagnosis, and notes that this group is at high risk of developing dementia, especially Alzheimer's disease. It also reports that a third of people with no clinical evidence of dementia had histopathological hallmarks of Alzheimer's disease, and it offers no treatment or cure.

  15. Insomnia in ischemic stroke patients

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Cerebrovascular diseases (Basel, Switzerland) 2002-01-01 Vascular contributions

    This is the first study that focuses on insomnia in stroke patients.

  16. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2001-06-26 Mild cognitive impairment

    Data point to a role for midlife vascular risk factors in the development of MCI in late life.

    Why it matters

    Among 1,449 Finnish people reexamined at ages 65 to 79 after an average of 21 years, 6.1% met criteria for mild cognitive impairment. Elevated cholesterol in midlife was a significant risk factor for mild cognitive impairment in late life, and the effect of systolic blood pressure approached significance.

  17. Magnetic resonance spectroscopy in AD

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2001-03-01 Mild cognitive impairment

    Proton MR spectroscopy (MRS) studies have found both decreased N-acetylaspartate (NAA) and increased myo-inositol in the occipital, temporal, parietal, and frontal regions of patients with AD, even at the early stages of the disease.

    Why it matters

    This review describes magnetic resonance spectroscopy findings such as decreased NAA and increased myo-inositol in Alzheimer's disease, even at early stages. It discusses the technique's promise for diagnosis and monitoring treatment, but reports no treatment or cure.

  18. A cross-national survey of tube-feeding decisions in cognitively impaired older persons

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of the American Geriatrics Society 2000-04-01 Disparities

    Despite the difference in diagnostic indication for tube-feeding, the substitute decision-making process was seriously limited at both sites by poor implementation of the principle of substituted judgement, a need for broader advance directives, and improved transfer of knowledge between clinicians and decision-makers.

    Why it matters

    This survey compared tube-feeding decisions for cognitively impaired older patients in US and Canadian care settings, finding that more patients in Boston had feeding tubes inserted because of degenerative dementia. It concerns decision-making about feeding tubes, not the treatment, cure, or prevention of Alzheimer's disease.

  19. Rate of memory decline in AD is related to education and occupation: cognitive reserve?

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 1999-12-01 Vascular contributions

    Memory declined more rapidly in AD patients with higher educational and occupational attainment.

  20. Development of an activities of daily living scale to screen for dementia in an illiterate rural older population in India

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Age and ageing 1999-03-01 Disparities

    Design identification of relevant items, pre-testing of items and refinement of administrative procedures and scoring in four successive groups of 30 subjects each, pilot testing in a group of 100 subjects comparable to those for whom the measure is intended, administration to a representative sample of 387 people aged 55 and older, and assessment of the reliability of the final measure.

    Why it matters

    This paper describes the development of a brief activities of daily living scale for screening dementia in illiterate rural older people in India, with good reliability and validity. It is a measurement tool and does not test a treatment, cure or prevention for Alzheimer's disease.

  21. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of neuropathology and experimental neurology 1999-01-01 Biomarkers

    Sleep disruption and other circadian rhythm disturbances are frequently seen in dementia patients.

    Why it matters

    In brain tissue from people who had severe dementia, the suprachiasmatic nucleus showed loss of vasopressin and neurotensin neurons and increased astrocyte staining, though damage there was less severe than in other brain regions. This describes brain changes associated with dementia and does not offer a treatment, cure, or prevention.

  22. Stress reduction for family caregivers: effects of adult day care use

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. The journals of gerontology. Series B, Psychological sciences and social sciences 1998-09-01 Caregiving

    These results demonstrate that use of adult day care by caregivers of dementia patients results in lower levels of caregiving-related stress and better psychological well-being when compared to that of controls.

    Why it matters

    This study found that family caregivers who used adult day care had lower levels of caregiving-related stress and better psychological well-being than those who did not. It addresses caregiver support and does not test a treatment for Alzheimer's disease itself.

  23. Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 1998-07-01 Caregiving

    Alzheimer's disease (AD) and other dementias are common degenerative disorders in the elderly.

    Why it matters

    This 1998 review describes how caring for a family member with Alzheimer's or another dementia — usually as an older spouse at home — is linked to significant psychological and physical strain, though caregivers differ widely in how well they adapt. It reports that the data "suggest" caregiver factors may influence whether the patient moves to institutional care, and that patients living with highly distressed caregivers may show more agitation and behaviour problems. It offers physicians a model for assessing caregivers and referring them to support; it is not a treatment for the disease and does not test whether the model works.

  24. The prevalence and 3-year incidence of dementia in older Black and White community residents

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of clinical epidemiology 1998-07-01 Disparities

    Prevalence, 3-year incidence, and types of dementia are comparable in Black and White elderly in the Piedmont area of North Carolina.

    Why it matters

    This study found that the prevalence of dementia was similar in older Black and White community residents, and differences by race or gender were not significant. It provides information about how common dementia is in these groups but does not test any treatment, cure, or prevention.

  25. Prevalence of cognitive impairment and dementia appear not to vary widely across the centres examined in this study, which provides stable estimates by age and sex for AGECAT O3 and above, and norms for MMSE.

    Why it matters

    This prevalence survey in six areas of England and Wales found that major influences on MMSE scores were age, sex, social class, and educational level. It estimated that around half a million people in England and Wales would be defined as case level by the method used, and found no heterogeneity in prevalence across the five centres employing the same methodology.

From across this topic

10 of the 7,981 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics